Treatment of neurodegenerative disorders

Details for Australian Patent Application No. 2006298826 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Haselbeck, Anton; Jarsch, Michael; Herting, Frank; Huwyler, Joerg

Agent Spruson & Ferguson

Pub. Number AU-B-2006298826

PCT Pub. Number WO2007/039436

Priority 05108946.4 28.09.05 EP

Filing date 18 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 1 April 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039436 Priority application(s): WO2007/039436

1 April 2010 Application Accepted

  Published as AU-B-2006298826

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298827-Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents

2006298825-Dispersing agents in composites